Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
I’m going to throw you the proverbial bone in the form of a chart as we put the finishing touches on an amazing new improvement I hope to roll out this evening. In the meanwhile, may I suggest The Medicines Company as a short, as it seems engaged in a clean series of lower lows and lower highs.
As we await the Fed…………….Three biotechs, along with recent IPO Pinterest (PINS), are among our four charts to watch today.
G1 Therapeutics, Inc. (GTHX) jumped $4.75, or 24%, to $24.50 on 2.2 million shares Tuesday. The move, on over 5 times its average volume, came on news of encouraging data from the company’s phase 2 study of its trilaciclib treatment for metastatic triple-negative breast cancer. The stock has next resistance at its May high at $27.90, a move through which could take it to $30.
(more…)
Me and the boys were up late last night doing server work. We’re making Slope Speed the top priority, and I hope by the end of this month I can announce some specific metrics in terms of speed improvement. No one uses Slope more than yours truly, and I want it, and SlopeCharts, to be as fast as possible.
My two favorite bullish stocks are Qudian and Lyft (yes, you are still reading the Slope of Hope). I wanted to offer a couple of price targets on each. Qudian still needs to push past the red horizontal I’ve drawn to complete its pattern, but I’m targeting a 60% move from present price levels, assuming that it does indeed conquer that red line.
(more…)
